4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid

C44H58N4O6 — CID 78147564

IUPAC4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
SMILESCC(C)C1=C2C3CCC4C5(C)CCC(OC(=O)CC(C)(C)C(=O)O)C(C)(C)C5CCC4(C)C3(C)CCC2(Cc2nnc(-c3ccc(C#N)cn3)o2)CC1=O
InChIInChI=1S/C44H58N4O6/c1-25(2)35-29(49)20-44(21-33-47-48-37(54-33)28-12-10-26(23-45)24-46-28)19-18-42(8)27(36(35)44)11-13-31-41(7)16-15-32(53-34(50)22-39(3,4)38(51)52)40(5,6)30(41)14-17-43(31,42)9/h10,12,24-25,27,30-32H,11,13-22H2,1-9H3,(H,51,52)
InChIKeyPNSBATLUKHIIDB-UHFFFAOYSA-N
MW738.97 g/mol
LogP8.94
Rot. Bonds8

About 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid

4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid (PubChem CID 78147564) has the molecular formula C44H58N4O6 and a molecular weight of 738.97 g/mol. Its IUPAC name is 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid.

Molecular Properties

Compound Name4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
PubChem CID78147564
Molecular FormulaC44H58N4O6
Molecular Weight738.97 g/mol
Exact Mass738.44
IUPAC Name4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
SMILESCC(C)C1=C2C3CCC4C5(C)CCC(OC(=O)CC(C)(C)C(=O)O)C(C)(C)C5CCC4(C)C3(C)CCC2(Cc2nnc(-c3ccc(C#N)cn3)o2)CC1=O
InChIInChI=1S/C44H58N4O6/c1-25(2)35-29(49)20-44(21-33-47-48-37(54-33)28-12-10-26(23-45)24-46-28)19-18-42(8)27(36(35)44)11-13-31-41(7)16-15-32(53-34(50)22-39(3,4)38(51)52)40(5,6)30(41)14-17-43(31,42)9/h10,12,24-25,27,30-32H,11,13-22H2,1-9H3,(H,51,52)
InChIKeyPNSBATLUKHIIDB-UHFFFAOYSA-N
XLogP8.94
TPSA156.27 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms54
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500738.97
LogP ≤ 58.94
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[[(3aR,5aR,5bR,9S,11aR,11bR,13aS)-3a-[[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
CID 138456657
4-[[3a-[5-(5-bromo-2-pyridinyl)-1,3,4-oxadiazol-2-yl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
CID 123963048
4-[[(3aR,5aR,5bR,7aR,9S,11aR,13aS)-3a-[[5-(4-cyanophenyl)-4-[2-(dimethylamino)ethyl]-1,2,4-triazol-3-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
CID 138456400
4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
CID 138456486
4-[[5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-3a-(5-pyrimidin-5-yl-1,3,4-oxadiazol-2-yl)-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
CID 123658682
4-[5-[[(3R,4S,5R,8S,9R,10R,13R)-4-[(3R)-3-[4-[5-[5-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]methyl]-1,3,4-oxadiazol-2-yl]-2-cyanophenyl]-3-carboxy-3-methylbutanoyl]oxypentyl]-3,4,9,10-tetramethyl-16-oxo-15-propan-2-yl-1,2,3,5,6,7,8,11,12,17-decahydrocyclopenta[a]phenanthren-13-yl]methyl]-1,3,4-oxadiazol-2-yl]benzoic acid
CID 138456517
4-[[3a-[5-(2,6-dichlorophenyl)-1,3,4-oxadiazol-2-yl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
CID 123770203
4-[[(3aR,5aR,5bR,9S,11aR,13aS)-3a-[2-[carboxymethyl(propan-2-yl)amino]ethyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
CID 130397262
4-[[(3aS,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-[5-(5-fluoro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]-5a,5b,8,8,11a-pentamethyl-1-propan-2-yl-2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a-tetradecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
CID 71678534
2-[[3-[5-[(3aR,5aR,5bR,9S,11aR,13aS)-9-(3-carboxy-3-methylbutanoyl)oxy-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-3a-yl]-1,3,4-oxadiazol-2-yl]-4-fluorophenyl]methyl]-4-[[(3aR,5aR,5bR,9S,11aR,11bR,13aS)-3a-[5-(5-fluoro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2-methyl-4-oxobutanoic acid
CID 138456597
4-[[(3aR,5aR,5bR,9S,11aR,13aS)-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-3a-(pyrimidin-2-ylcarbamoyl)-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
CID 70995157
4-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-5a,5b,8,8,11a-pentamethyl-3a-[2-(4-methylpyrimidin-5-yl)acetyl]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
CID 58206766

Frequently Asked Questions

What is the IUPAC name of 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The IUPAC name of 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid (CID 78147564) is 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid.
What is the SMILES notation for 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The canonical SMILES for 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid is CC(C)C1=C2C3CCC4C5(C)CCC(OC(=O)CC(C)(C)C(=O)O)C(C)(C)C5CCC4(C)C3(C)CCC2(Cc2nnc(-c3ccc(C#N)cn3)o2)CC1=O.
What is the InChIKey of 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The InChIKey is PNSBATLUKHIIDB-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H58N4O6/c1-25(2)35-29(49)20-44(21-33-47-48-37(54-33)28-12-10-26(23-45)24-46-28)19-18-42(8)27(36(35)44)11-13-31-41(7)16-15-32(53-34(50)22-39(3,4)38(51)52)40(5,6)30(41)14-17-43(31,42)9/h10,12,24-25,27,30-32H,11,13-22H2,1-9H3,(H,51,52).
What are the key properties of 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid has a molecular weight of 738.97 g/mol, XLogP of 8.94, 8 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[3a-[[5-(5-cyano-2-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid is sourced from PubChem (CID 78147564), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).